FDA Warns Oral Contraceptives – Yaz, Yasmin – Have High Risk Of Blood Clots

Oral contraceptives that contain drospirenone have a threefold increase for risk of blood clots

The FDA (Food and Drug Administration) “has concluded that drospirenone containing birth control pills may be associated with a higher risk for blood clots than other progestin containing pills.”

Nine oral contraceptives containing 3mg of drospirenone and either 0.02 or 0.03 mg of ethinyl estradiol, will now note the risk of blood clots on their labels.  The oral contraceptives include:  Yaz, Yasmin, Ocella, Zarah, Beyaz, Gianvi, Syeda, Loryna, Safyral.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>